Update on Omicron Variant and Covid-19 Vaccines

Latest update on Omicron variantKaiser Permanente is closely monitoring the Omicron variant, and continues to learn about its transmission rate or whether it causes more severe illness. Current vaccines are expected to protect against severe illness, hospitalizations, and deaths due to infection with the Omicron variant. However, breakthrough infections in people who are fully vaccinated…

Read More

What to Know about the Covid-19 Omicron Variant

Is the Omicron variant contagious? The Omicron variant spreads more faster than the other variants. What are the Omicron variant symptoms? There is no information to suggest that Omicron causes different COVID-19 symptoms from other COVID-19 variants. How severe is the Omicron variant? Early findings suggest that Omicron is less severe than the Delta variant.…

Read More

CDC Expands Covid-19 Vaccine Booster Eligibility

On November 23, Kaiser Permanente informs the public that the CDC’s Advisory Committee on Immunization Practices (ACIP) has recommended booster doses of the Moderna and Pfizer COVID-19 vaccines for all adults 18 years and older in alignment with the FDA’s expansion of the emergency use authorization for both vaccines. For those who received their primary…

Read More

Moderna and J&J COVID-19 Booster Shots Update

On September 26, Kaiser Permanente informs the public that the Centers for Disease Control and Prevention (CDC) recommends booster doses of the Moderna and Johnson & Johnson COVID-19 vaccines for certain groups. Moderna: For people who received two doses of the Moderna vaccine at least six months ago, the committee recommended a booster dose for: People 65 or…

Read More